» Articles » PMID: 34943088

Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles

Overview
Date 2021 Dec 24
PMID 34943088
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Pheophorbide a 17-diethylene glycol ester (XL-8), is a promising high-active derivative of known photosensitizer chlorin e6 used in photodynamic therapy. However, high lipophilicity and poor tumor accumulation limit XL-8 therapeutic application. We developed a novel XL-8 loaded with poly(D,L-lactide-co-glycolide) nanoparticles using the single emulsion-solvent evaporation method. The nanoparticles possessed high XL-8 loading content (4.6%) and encapsulation efficiency (87.7%) and a small size (182 ± 19 nm), and negative surface charge (-22.2 ± 3.8 mV) contributed to a specific intracellular accumulation. Sustained biphasic XL-8 release from nanoparticles enhanced the photosensitizer photostability upon irradiation that could potentially reduce the quantity of the drug applied. Additionally, the encapsulation of XL-8 in the polymer matrix preserved phototoxic activity of the payload. The nanoparticles displayed enhanced cellular internalization. Flow cytometry and confocal laser-scanning microscopy studies revealed rapid XL-8 loaded nanoparticles distribution throughout the cell and initiation of DNA damage, glutathione depletion, and lipid peroxidation via reactive oxygen species formation. The novel nanoformulated XL-8 simultaneously revealed a significant phototoxicity accompanied with enhanced photostability, in contrast with traditional photosensitizers, and demonstrated a great potential for further in vivo studies.

Citing Articles

Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α Derivative.

Sokol M, Beganovskaya V, Mollaeva M, Yabbarov N, Chirkina M, Belykh D Pharmaceutics. 2024; 16(1).

PMID: 38258135 PMC: 10818748. DOI: 10.3390/pharmaceutics16010126.


Biomimetic Materials Based on Poly-3-hydroxybutyrate and Chlorophyll Derivatives.

Tyubaeva P, Gasparyan K, Romanov R, Kolesnikov E, Martirosyan L, Larkina E Polymers (Basel). 2024; 16(1).

PMID: 38201766 PMC: 10780539. DOI: 10.3390/polym16010101.


Synthesis and Biological Properties of EGFR-Targeted Photosensitizer Based on Cationic Porphyrin.

Bortnevskaya Y, Shiryaev N, Zakharov N, Kitoroage O, Gradova M, Karpechenko N Pharmaceutics. 2023; 15(4).

PMID: 37111769 PMC: 10145264. DOI: 10.3390/pharmaceutics15041284.


Carboxylated superparamagnetic FeO nanoparticles modified with 3-amino propanol and their application in magnetic resonance tumor imaging.

Wang C, Wang Y, Xiao W, Chen X, Li R, Shen Z BMC Cancer. 2023; 23(1):54.

PMID: 36647053 PMC: 9841710. DOI: 10.1186/s12885-023-10514-0.


Structural Optimization of Platinum Drugs to Improve the Drug-Loading and Antitumor Efficacy of PLGA Nanoparticles.

Sokol M, Chirkina M, Yabbarov N, Mollaeva M, Podrugina T, Pavlova A Pharmaceutics. 2022; 14(11).

PMID: 36365151 PMC: 9698263. DOI: 10.3390/pharmaceutics14112333.


References
1.
Pala L, Senn H, Caldwell S, Prime T, Warrington S, Bright T . Enhancing the Mitochondrial Uptake of Phosphonium Cations by Carboxylic Acid Incorporation. Front Chem. 2020; 8:783. PMC: 7509049. DOI: 10.3389/fchem.2020.00783. View

2.
Manzari M, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller D . Targeted drug delivery strategies for precision medicines. Nat Rev Mater. 2021; 6(4):351-370. PMC: 8691416. DOI: 10.1038/s41578-020-00269-6. View

3.
Liu T, Liu W, Zhang M, Yu W, Gao F, Li C . Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy. ACS Nano. 2018; 12(12):12181-12192. DOI: 10.1021/acsnano.8b05860. View

4.
Hua X, Tan S, Bandara H, Fu Y, Liu S, Smyth H . Externally controlled triggered-release of drug from PLGA micro and nanoparticles. PLoS One. 2014; 9(12):e114271. PMC: 4257591. DOI: 10.1371/journal.pone.0114271. View

5.
Attia M, Anton N, Wallyn J, Omran Z, Vandamme T . An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol. 2019; 71(8):1185-1198. DOI: 10.1111/jphp.13098. View